Yücel, K. B. Et Al. 2024. Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors. Cancer Chemotherapy and Pharmacology , vol.93, no.5 , 497-507.

Yücel, K. B., AYDOS, U., SÜTCÜOĞLU, O., Kılıç, A. C. K., ÖZDEMİR, N., ÖZET, A., ... YAZICI, O.(2024). Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors. Cancer Chemotherapy and Pharmacology , vol.93, no.5, 497-507.

Yücel, Kadriye Et Al. "Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors," Cancer Chemotherapy and Pharmacology , vol.93, no.5, 497-507, 2024

Yücel, Kadriye B. Et Al. "Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors." Cancer Chemotherapy and Pharmacology , vol.93, no.5, pp.497-507, 2024

Yücel, K. B. Et Al. (2024) . "Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors." Cancer Chemotherapy and Pharmacology , vol.93, no.5, pp.497-507.

@article{article, author={Kadriye Bir Yücel Et Al. }, title={Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors}, journal={Cancer Chemotherapy and Pharmacology}, year=2024, pages={497-507} }